TGFB1 and systemic sclerosis: It has been suggested that intrinsic activation of TGF-β in SSc fibroblasts could in turn inhibit expression of IL-17 receptor in fibroblasts, leading to an amplification of collagen levels and fibrosis in SSc (47).